Pharmacokinetics of Melagatran and the Effect on Ex Vivo Coagulation Time in Orthopedic Surgery Patients Receiving Subcutaneous Melagatran and Oral Ximelagatran: A Population Model Analysis

Author(s): Ulf Eriksson, Jaap Mandema, Mats Karlsson, Lars Frison, Per Olsson Gisleskog, Ulrika Wählby, Bengt Hamrén, David Gustafsson, Bengt Eriksson
Year: January 1, 2003
Learn More LinkedIn Twitter Facebook Email